Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brazil.
Front Immunol. 2021 Mar 16;12:654574. doi: 10.3389/fimmu.2021.654574. eCollection 2021.
The small molecule (molecular mass <900 Daltons) composition of extracellular vesicles (EVs) produced by the pathogenic fungus is unknown, which limits the understanding of the functions of cryptococcal EVs. In this study, we analyzed the composition of small molecules in samples obtained from solid cultures of by a combination of chromatographic and spectrometric approaches, and untargeted metabolomics. This analysis revealed previously unknown components of EVs, including small peptides with known biological functions in other models. The peptides found in EVs had their chemical structure validated by chemical approaches and comparison with authentic standards, and their functions tested in a model of cryptococcal infection. One of the vesicular peptides (isoleucine-proline-isoleucine, Ile-Pro-Ile) improved the survival of lethally infected with or . These results indicate that small molecules exported in EVs are biologically active in . Our study is the first to characterize a fungal EV molecule inducing protection, pointing to an immunological potential of extracellular peptides produced by .
外泌体(EV)是由致病真菌产生的一种微小囊泡,其小分子(分子量<900 道尔顿)组成未知,这限制了对隐球菌 EV 功能的理解。在这项研究中,我们采用色谱和光谱方法以及非靶向代谢组学相结合的方法,分析了从致病真菌固体培养物中获得的样本中小分子的组成。该分析揭示了 EV 中以前未知的成分,包括在其他模型中具有已知生物学功能的小肽。通过化学方法和与标准品的比较,验证了在 EV 中发现的肽的化学结构,并在隐球菌感染模型中测试了它们的功能。囊泡中的一种肽(异亮氨酸-脯氨酸-异亮氨酸,Ile-Pro-Ile)提高了致死性感染的存活率或。这些结果表明,外泌体中输出的小分子在中具有生物活性。我们的研究首次描述了一种诱导保护作用的真菌 EV 分子,这表明由产生的细胞外肽具有免疫潜力。